Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Targeted Oncology Year : 2022

Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis

Abstract

Background Information on the epidemiology of uncommon EGFR mutations including exon 20 insertions amongst nonsmall-cell lung cancer (NSCLC) is lacking. Objective The objective of this pragmatic literature review (PLR) and meta-analysis was to generate robust prevalence and incidence estimates based on ranges of exon 20 insertion mutations reported in the literature. Materials and methods Searches of MEDLINE, Embase, congresses and reference lists for articles published from 2013 in key European countries of interest

Domains

Cancer
Fichier principal
Vignette du fichier
11523_2022_Article_868.pdf (2.08 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-04141993 , version 1 (26-06-2023)

Identifiers

Cite

Suzy van Sanden, Molly Murton, Anna Bobrowska, Nora Rahhali, Jan Sermon, et al.. Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis. Targeted Oncology, 2022, 17 (2), pp.153 - 166. ⟨10.1007/s11523-022-00868-z⟩. ⟨hal-04141993⟩

Collections

IMRB UPEC
2 View
14 Download

Altmetric

Share

Gmail Facebook X LinkedIn More